85 related articles for article (PubMed ID: 1828826)
41. T3 monoclonal antibody activation of nonspecific cytolysis: a mechanism of CTL inhibition.
Mentzer SJ; Barbosa JA; Burakoff SJ
J Immunol; 1985 Jul; 135(1):34-8. PubMed ID: 2582036
[TBL] [Abstract][Full Text] [Related]
42. Studies on the cytolytic attack mechanism of the cytotoxic T lymphocyte (CTL): preparation of antisera against cellfree cytosolic extracts of a CTL clone capable of blocking the lethal hit stage of CTL cytolysis and analysis of the cytolytic structure.
Hiserodt JC
J Immunol; 1985 Jul; 135(1):53-62. PubMed ID: 3158707
[TBL] [Abstract][Full Text] [Related]
43. Target cell lysis by cytotoxic T lymphocytes redirected by antibody-coated polystyrene beads.
Kolber MA; Quinones RR; Henkart PA
J Immunol; 1989 Sep; 143(5):1461-6. PubMed ID: 2668408
[TBL] [Abstract][Full Text] [Related]
44. Cell surface molecules involved in NK recognition by cloned cytotoxic T lymphocytes.
Brooks CG; Holscher M
J Immunol; 1987 Mar; 138(5):1331-7. PubMed ID: 3543127
[TBL] [Abstract][Full Text] [Related]
45. An autologous T cell clone overcomes intra-melanoma heterogeneity for susceptibility to cell-mediated lysis by using multiple lytic mechanisms: in vitro and in vivo analysis.
Mazzocchi A; Rodolfo M; Parmiani G; Anichini A
Melanoma Res; 1991; 1(3):169-76. PubMed ID: 1841713
[TBL] [Abstract][Full Text] [Related]
46. The mechanism of anti-Lyt-2 inhibition of antibody-directed lysis by cytotoxic T lymphocytes.
Langlet C; Neil GA; Sherman LA
J Immunol; 1987 Dec; 139(11):3590-6. PubMed ID: 3500224
[TBL] [Abstract][Full Text] [Related]
47. T lymphocyte-mediated cytolysis. II. Role of target cell histocompatibility antigens in recognition and lysis.
Berke G; McVey E; Hu V; Clark WR
J Immunol; 1981 Aug; 127(2):782-7. PubMed ID: 6265557
[TBL] [Abstract][Full Text] [Related]
48. Cytolysis of leukemic B-cells by T-cells activated via two bispecific antibodies.
Bohlen H; Manzke O; Patel B; Moldenhauer G; Dörken B; von Fliedner V; Diehl V; Tesch H
Cancer Res; 1993 Sep; 53(18):4310-4. PubMed ID: 7689932
[TBL] [Abstract][Full Text] [Related]
49. Identification of monoclonal antibodies specific for the T cell receptor complex by Fc receptor-mediated CTL lysis.
Leo O; Sachs DH; Samelson LE; Foo M; Quinones R; Gress R; Bluestone JA
J Immunol; 1986 Dec; 137(12):3874-80. PubMed ID: 3097135
[TBL] [Abstract][Full Text] [Related]
50. Cholera toxin inhibits the increase in cytoplasmic free calcium induced via the CD2 pathway of human T-lymphocyte activation.
Nunes J; Bagnasco M; Lopez M; Olive D; Mawas C
J Cell Biochem; 1989 Apr; 39(4):391-400. PubMed ID: 2542344
[TBL] [Abstract][Full Text] [Related]
51. Studies on the mechanism of suppression of primary cytotoxic responses by cloned cytotoxic T lymphocytes.
Fink PJ; Rammensee HG; Benedetto JD; Staerz UD; Lefrancois L; Bevan MJ
J Immunol; 1984 Oct; 133(4):1769-74. PubMed ID: 6236258
[TBL] [Abstract][Full Text] [Related]
52. Energy requirements of the binding and lytic steps of T lymphocyte-mediated cytolysis of leukemic cells in vitro.
Berke G; Gabison D
Eur J Immunol; 1975 Oct; 5(10):671-5. PubMed ID: 11993332
[TBL] [Abstract][Full Text] [Related]
53. Increased intracellular cyclic adenosine monophosphate inhibits T lymphocyte-mediated cytolysis by two distinct mechanisms.
Gray LS; Gnarra J; Hewlett EL; Engelhard VH
J Exp Med; 1988 Jun; 167(6):1963-8. PubMed ID: 2838563
[TBL] [Abstract][Full Text] [Related]
54. Cytolytic T lymphocytes: an overview of their characteristics.
Lancki DW; Fitch FW
Biotherapy; 1992; 5(1):71-81. PubMed ID: 1389904
[TBL] [Abstract][Full Text] [Related]
55. Extracellular ATP as a possible mediator of cell-mediated cytotoxicity.
Di Virgilio F; Pizzo P; Zanovello P; Bronte V; Collavo D
Immunol Today; 1990 Aug; 11(8):274-7. PubMed ID: 2206271
[TBL] [Abstract][Full Text] [Related]
56. Enhancement of redirected target cell lysis by cytotoxic T lymphocytes in the presence of cytochalasin B.
Kolber MA
Cell Immunol; 1991 Mar; 133(1):84-94. PubMed ID: 1991331
[TBL] [Abstract][Full Text] [Related]
57. Immune cytolysis viewed as a stimulatory process of the target.
Tirosh R; Berke G
Adv Exp Med Biol; 1985; 184():473-92. PubMed ID: 3898757
[TBL] [Abstract][Full Text] [Related]
58. Marking hypoxic cells for complement and cytotoxic T lymphocyte-mediated lysis: using pimonidazole.
Chou SC; Flood PM; Raleigh JA
Br J Cancer Suppl; 1996 Jul; 27():S213-6. PubMed ID: 8763883
[TBL] [Abstract][Full Text] [Related]
59. Effect of conjugate size on the kinetics of cell-mediated cytotoxicity at the population level.
Garcia-Peñarrubia P; Koster FT; Bankhurst AD; Galvez J
J Theor Biol; 1989 May; 138(1):93-115. PubMed ID: 2626066
[TBL] [Abstract][Full Text] [Related]
60. Resistance of cytolytic T lymphocytes to the lytic components they release.
Eisen HN; Verret CR; Firmenich AA; Kranz DM
Ann Inst Pasteur Immunol; 1987; 138(2):328-31. PubMed ID: 3496910
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
